Fibrosis-4 index predicts cirrhosis risk and liver-related mortality in 2075 patients with chronic HBV infection.
Tai-Chung TsengChun-Jen LiuT-H SuW-T YangC-L ChenH-C YangS F-T KuoC-H LiuP-J ChenD-S ChenJia-Horng KaoPublished in: Alimentary pharmacology & therapeutics (2018)
In noncirrhotic patients with chronic HBV infection, a higher FIB-4 index was associated with increased risks of adverse liver events. FIB-4 index <1.29 is useful for the prediction of the lowest risks of disease progression.